Información del producto
- (4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-9-[[(2,2-dimethylpropyl)amino]methyl]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
- 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-[[(2,2-dimethylpropyl)amino]methyl]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-
- Amadacycline
- Bay 73-7388
- Mk 2764
- Ptk-0796
Omadacycline is a p-glycoprotein inhibitor that has been shown to be effective against antibiotic-resistant strains of bacteria. It is active against aerobic, anaerobic, and facultative bacteria and has activity against both Gram-positive and Gram-negative organisms. Omadacycline was approved by the FDA in 2017 for the treatment of complicated skin and skin structure infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA) or multidrug-resistant Enterobacteriaceae. This drug binds to bacterial ribosomes, inhibiting protein synthesis and stopping cell division. Omadacycline has been shown to be safe and well tolerated in clinical trials.
Propiedades químicas
Consulta técnica sobre: 3D-PQA13989 Omadacycline
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.